MYC and SMARCA2 |
v-myc avian myelocytomatosis viral oncogene homolog |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
- Loss of Function of TGFBR2 in Cancer
- Signaling by NOTCH1 HD Domain Mutants in Cancer
- Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
- SMAD2/3 MH2 Domain Mutants in Cancer
- Signaling by Wnt
- Cyclin E associated events during G1/S transition
- binding of TCF/LEF:CTNNB1 to target gene promoters
- TGFBR1 LBD Mutants in Cancer
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant
- Generic Transcription Pathway
- RNF mutants show enhanced WNT signaling and proliferation
- G1/S Transition
- Signaling by NOTCH1
- XAV939 inhibits tankyrase, stabilizing AXIN
- Signaling by NOTCH1 in Cancer
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- Mitotic G1-G1/S phases
- FBXW7 Mutants and NOTCH1 in Cancer
- TGFBR2 MSI Frameshift Mutants in Cancer
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
- Loss of Function of SMAD2/3 in Cancer
- Signaling by NOTCH
- formation of the beta-catenin:TCF transactivating complex
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- S Phase
- Cell Cycle, Mitotic
- Loss of Function of TGFBR1 in Cancer
- NOTCH1 Intracellular Domain Regulates Transcription
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- TCF dependent signaling in response to WNT
- Signaling by NOTCH1 PEST Domain Mutants in Cancer
- Cyclin A:Cdk2-associated events at S phase entry
- Signaling by WNT in cancer
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- SMAD4 MH2 Domain Mutants in Cancer
|
- Chromatin modifying enzymes
- Chromatin organization
- RMTs methylate histone arginines
|
|
|
|
|
MYO1A and DISC1 |
myosin IA |
disrupted in schizophrenia 1 |
|
|
|
|
|
|
MYO5B and TCF4 |
myosin VB |
transcription factor 4 |
- Vasopressin regulates renal water homeostasis via Aquaporins
- Aquaporin-mediated transport
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
MYOD1 and TCF4 |
myogenic differentiation 1 |
transcription factor 4 |
- CDO in myogenesis
- Myogenesis
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
MYOD1 and RORA |
myogenic differentiation 1 |
RAR-related orphan receptor A |
- CDO in myogenesis
- Myogenesis
|
- PPARA activates gene expression
- Fatty acid, triacylglycerol, and ketone body metabolism
- Metabolism of lipids and lipoproteins
- Generic Transcription Pathway
- Nuclear Receptor transcription pathway
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- REV-ERBA represses gene expression
- BMAL1:CLOCK,NPAS2 activates circadian gene expression
- RORA activates circadian gene expression
|
|
|
|
|
HNRNPM and PRRC2A |
heterogeneous nuclear ribonucleoprotein M |
proline-rich coiled-coil 2A |
- Processing of Capped Intron-Containing Pre-mRNA
- mRNA Splicing
- mRNA Splicing - Major Pathway
|
|
|
|
|
|
NARS and LSM1 |
asparaginyl-tRNA synthetase |
LSM1, U6 small nuclear RNA associated |
- Cytosolic tRNA aminoacylation
- tRNA Aminoacylation
|
- mRNA decay by 5' to 3' exoribonuclease
- Deadenylation-dependent mRNA decay
|
|
|
|
|
NBL1 and BAG6 |
neuroblastoma 1, DAN family BMP antagonist |
BCL2-associated athanogene 6 |
|
|
|
|
|
|
NCK1 and TNIK |
NCK adaptor protein 1 |
TRAF2 and NCK interacting kinase |
- Signaling by PDGF
- Signaling by the B Cell Receptor (BCR)
- Generation of second messenger molecules
- Axon guidance
- DCC mediated attractive signaling
- VEGFA-VEGFR2 Pathway
- TCR signaling
- Activation of Rac
- Signaling by VEGF
- Downstream signal transduction
- Nephrin interactions
- Netrin-1 signaling
- Fcgamma receptor (FCGR) dependent phagocytosis
- Signaling by Robo receptor
- Regulation of actin dynamics for phagocytic cup formation
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Adaptive Immune System
- Innate Immune System
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
NCK1 and MAP4K4 |
NCK adaptor protein 1 |
mitogen-activated protein kinase kinase kinase kinase 4 |
- Signaling by PDGF
- Signaling by the B Cell Receptor (BCR)
- Generation of second messenger molecules
- Axon guidance
- DCC mediated attractive signaling
- VEGFA-VEGFR2 Pathway
- TCR signaling
- Activation of Rac
- Signaling by VEGF
- Downstream signal transduction
- Nephrin interactions
- Netrin-1 signaling
- Fcgamma receptor (FCGR) dependent phagocytosis
- Signaling by Robo receptor
- Regulation of actin dynamics for phagocytic cup formation
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
- Adaptive Immune System
- Innate Immune System
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
NDUFA6 and BAG6 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
BCL2-associated athanogene 6 |
- Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
- Respiratory electron transport
- The citric acid (TCA) cycle and respiratory electron transport
|
|
|
|
|
|
NDUFB9 and FEZ1 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa |
fasciculation and elongation protein zeta 1 (zygin I) |
- Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.
- Respiratory electron transport
- The citric acid (TCA) cycle and respiratory electron transport
|
|
|
|
|
|
NEDD4 and TNIK |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
TRAF2 and NCK interacting kinase |
- Downregulation of ERBB4 signaling
- Antigen processing: Ubiquitination & Proteasome degradation
- ISG15 antiviral mechanism
- Interferon Signaling
- Cytokine Signaling in Immune system
- Class I MHC mediated antigen processing & presentation
- Signaling by ERBB4
- Antiviral mechanism by IFN-stimulated genes
- Adaptive Immune System
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
NEFM and TNIK |
neurofilament, medium polypeptide |
TRAF2 and NCK interacting kinase |
|
- Oxidative Stress Induced Senescence
- Cellular Senescence
|
|
|
|
|
NEFM and DISC1 |
neurofilament, medium polypeptide |
disrupted in schizophrenia 1 |
|
|
|
|
|
|
NEK1 and FEZ1 |
NIMA-related kinase 1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
|
|
|
|
|
NEK2 and MAD1L1 |
NIMA-related kinase 2 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
- Organelle biogenesis and maintenance
- APC/C:Cdc20 mediated degradation of mitotic proteins
- Assembly of the primary cilium
- G2/M Transition
- Anchoring of the basal body to the plasma membrane
- Regulation of PLK1 Activity at G2/M Transition
- APC/C-mediated degradation of cell cycle proteins
- Cell Cycle, Mitotic
- Loss of proteins required for interphase microtubule organization from the centrosome
- Loss of Nlp from mitotic centrosomes
- Regulation of mitotic cell cycle
- Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
- APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
- Centrosome maturation
- Mitotic G2-G2/M phases
- Recruitment of mitotic centrosome proteins and complexes
|
- Mitotic Spindle Checkpoint
- Amplification of signal from the kinetochores
- Mitotic Prometaphase
- Separation of Sister Chromatids
- Resolution of Sister Chromatid Cohesion
- Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
- Cell Cycle Checkpoints
- Mitotic Anaphase
- Mitotic Metaphase and Anaphase
- Cell Cycle, Mitotic
- M Phase
|
|
|
|
|
NEUROD1 and TCF4 |
neuronal differentiation 1 |
transcription factor 4 |
- Regulation of beta-cell development
- Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells
- Regulation of gene expression in beta cells
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
NEUROG1 and TCF4 |
neurogenin 1 |
transcription factor 4 |
|
- CDO in myogenesis
- Myogenesis
|
|
|
|
|
NFKB1 and SP1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
Sp1 transcription factor |
- Signaling by the B Cell Receptor (BCR)
- NF-kB is activated and signals survival
- Downstream TCR signaling
- Toll Like Receptor 7/8 (TLR7/8) Cascade
- Cellular Senescence
- RIP-mediated NFkB activation via ZBP1
- Toll Like Receptor TLR6:TLR2 Cascade
- DEx/H-box helicases activate type I IFN and inflammatory cytokines production
- Activated TLR4 signalling
- Toll Like Receptor TLR1:TLR2 Cascade
- Downstream signaling events of B Cell Receptor (BCR)
- FCERI mediated NF-kB activation
- MyD88 cascade initiated on plasma membrane
- Toll Like Receptor 5 (TLR5) Cascade
- ZBP1(DAI) mediated induction of type I IFNs
- p75NTR signals via NF-kB
- Transcriptional regulation of white adipocyte differentiation
- MyD88 dependent cascade initiated on endosome
- TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
- MyD88:Mal cascade initiated on plasma membrane
- Toll Like Receptor 9 (TLR9) Cascade
- Innate Immune System
- Regulated proteolysis of p75NTR
- Signalling by NGF
- TRIF-mediated TLR3/TLR4 signaling
- Cytosolic sensors of pathogen-associated DNA
- Senescence-Associated Secretory Phenotype (SASP)
- Cytokine Signaling in Immune system
- p75 NTR receptor-mediated signalling
- MyD88-independent cascade
- Toll Like Receptor 2 (TLR2) Cascade
- RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
- Signaling by Interleukins
- TCR signaling
- Toll-Like Receptors Cascades
- Toll Like Receptor 10 (TLR10) Cascade
- Interleukin-1 processing
- Toll Like Receptor 3 (TLR3) Cascade
- Toll Like Receptor 4 (TLR4) Cascade
- Activation of NF-kappaB in B cells
- Fc epsilon receptor (FCERI) signaling
- TRAF6 mediated NF-kB activation
- Interleukin-1 signaling
- Adaptive Immune System
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
|
- Loss of Function of TGFBR2 in Cancer
- PPARA activates gene expression
- Metabolism of lipids and lipoproteins
- Cellular Senescence
- SMAD2/3 MH2 Domain Mutants in Cancer
- TGFBR1 LBD Mutants in Cancer
- Oncogene Induced Senescence
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
- Regulation of cholesterol biosynthesis by SREBP (SREBF)
- Generic Transcription Pathway
- TGFBR2 MSI Frameshift Mutants in Cancer
- Fatty acid, triacylglycerol, and ketone body metabolism
- SMAD2/3 Phosphorylation Motif Mutants in Cancer
- Loss of Function of SMAD2/3 in Cancer
- TGFBR2 Kinase Domain Mutants in Cancer
- Loss of Function of SMAD4 in Cancer
- TGFBR1 KD Mutants in Cancer
- Loss of Function of TGFBR1 in Cancer
- Signaling by TGF-beta Receptor Complex in Cancer
- Signaling by TGF-beta Receptor Complex
- Activation of gene expression by SREBF (SREBP)
- Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
- SMAD4 MH2 Domain Mutants in Cancer
|
- Thalidomide
- Pranlukast
- Triflusal
|
|
|
|